Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Integral Molecular is an industry leader in membrane protein and antibody technologies, supplying proprietary discovery platforms and reagents used in global antibody and vaccine discovery pipelines. Integral Molecular does not have its own drugs in clinical trials but enables antibody discovery for challenging targets (such as GPCRs, ion channels, and viral envelopes), with technologies used in developing therapeutics and vaccines for cancer, infectious, and autoimmune diseases[1][2][4][7][8].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Integral.